Corroborating that resistin levels could be a useful marker for COVID-19 disease outcome, it was identified in a cohort of 254 COVID-19-infected patients that serum resistin levels were higher in patients with severe disease compared to those patients with non-severe disease on the day of admission. Here, RETN is linked to COVID-19.